Biomea Fusion BMEA
NASDAQ BMEA
$1.37 +0.01 (+0.74%)
At close: Aug 21, 2026 · 4:00 PM EDT

Biomea Fusion (BMEA) Total Current Liabilities (2020 - 2026)

Biomea Fusion (BMEA) posted Total Current Liabilities of $9.3 million for Q1 2026, down 16.28% sequentially from $11.1 million in Q4 2025, and down 53.1% YoY from $19.8 million in Q1 2025.

Biomea Fusion (BMEA) Total Current Liabilities (2020 - 2026) Analysis & Trends

Biomea Fusion has reported Total Current Liabilities for 7 years, with the latest figure at $9.3 million in Q1 2026.

  • Quarterly Total Current Liabilities fell 53.1% year-over-year to $9.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $9.3 million (down 53.1% YoY) and the FY2025 annual result came in at $11.1 million, down 48.78% from the prior year.
  • Total Current Liabilities slipped to $9.3 million in Q1 2026 per BMEA's latest filing, from $11.1 million in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $27.6 million in Q3 2024 and troughed at $8.0 million in Q1 2022.
  • A 5-year average of $17.3 million and a median of $17.6 million in 2025 frame the typical range for Total Current Liabilities.
  • The sharpest annual moves came in 2022 and 2026: Total Current Liabilities jumped 311.93% in 2022, then sank 53.1% in 2026.
  • Over 5 years, Total Current Liabilities stood at $19.1 million in 2022, then climbed by 19.68% to $22.9 million in 2023, then decreased by 5.19% to $21.7 million in 2024, then tumbled by 48.78% to $11.1 million in 2025, then dropped by 16.28% to $9.3 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $9.3 million, $11.1 million, and $15.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 3.94 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 5.53 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.58 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.53 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 2.12 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 1.51 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 2.49 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 438.74 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 630.93 Mn
10 Biomea Fusion 97.69 Mn 97.69 Mn - 10.48 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 10.48 Mn
Mar 31, 2026 9.29 Mn
Dec 31, 2025 11.10 Mn
Sep 30, 2025 15.57 Mn
Jun 30, 2025 17.57 Mn
Mar 31, 2025 19.82 Mn
Dec 31, 2024 21.67 Mn
Sep 30, 2024 27.57 Mn
Jun 30, 2024 25.16 Mn
Mar 31, 2024 25.25 Mn
Dec 31, 2023 22.86 Mn
Sep 30, 2023 16.21 Mn
Jun 30, 2023 14.36 Mn
Mar 31, 2023 18.77 Mn
Dec 31, 2022 19.10 Mn
Sep 30, 2022 12.59 Mn
Jun 30, 2022 9.36 Mn
Mar 31, 2022 7.96 Mn
Dec 31, 2021 4.64 Mn
Sep 30, 2021 5.64 Mn